Hasil Pencarian (1)
small molecule | CAS: 14484-47-0
Deflazacort, also known as Emflaza, is a corticosteroid prodrug used as an agent to manage Duchenne Muscular Dystrophy (DMD). It is marketed by Marathon Pharmaceuticals and was approved in February 2017 by the FDA.[L6694,FDA label] Duchenne Muscular Dystro…
Kategori:
Adrenal Cortex HormonesAnti-Inflammatory AgentsCorticosteroid Hormone Receptor Agonists
+18
Target Protein:
Glucocorticoid receptor
Waktu ParuhThe half-life of de…
Vol. DistribusiOne study determine…
Klirens114 ±27 L/h, accord…
Genetik
-